Degenerative neurological disorders

MHRA advises health professionals on supply of clobazam for epilepsy

An epilepsy charity has updated its advice for health professionals on the supply of clobazam for people with epilepsy.…

MS charity says cannabis should be legalised for medicinal use

Cannabis should be legalised for medicinal use for people with multiple sclerosis (MS) to relieve their pain, a leading charity has advised.…

Analysis estimates more than 30 Alzheimer’s drugs will have launched by 2022

Over the next 5 years, 27 phase III and 8 phase II Alzheimer’s drugs may be launched, according to a pipeline analysis carried out by ResearchersAgainstAlzheimer’s…

New guidelines on Parkinson’s disease released by NICE

The National Institute for Health and Care Excellence (NICE), England’s health technology assessment body, has released new clinical guidelines on the diagnosis and management of Parkinson’s disease in adults aged 18 years and over.…

Alzheimer’s treatment explored as potential Down’s syndrome therapy

Phase II study finds Alzheimer’s disease-modifying drug is safe for patients with Down’s syndrome, but concludes more research is needed to test effects on cognitive function.…

Protein can assess and predict progression of Huntington’s disease

Researchers identify biomarker that offers a means of predicting and tracking neuronal damage in patients with Huntington’s disease.…

Flu might increase risk of Parkinson’s disease

Researchers observe a link between flu virus infection and Parkinson’s disease pathology, strengthening the case for flu vaccination and prompt antiviral treatment.…

What neuroscience pharmacist Viv Horton does for movement disorder and Parkinson’s services

As a neuroscience pharmacist, Viv Horton sees patients in a movement disorder clinic and Parkinson’s Advanced Symptom Unit, and delivers ward-based medicines optimisation services covering neurology, neurosurgery, neurorehabilitation and stroke services.…

What neuroscience pharmacist Viv Horton does for movement disorder and Parkinson’s services

As a neuroscience pharmacist, Viv Horton sees patients in a movement disorder clinic and Parkinson’s Advanced Symptom Unit, and delivers ward-based medicines optimisation services covering neurology, neurosurgery, neurorehabilitation and stroke services.…

Minocycline acne drug may offer new treatment for multiple sclerosis

The acne drug minocycline has been shown to slow the progress of relapsing-remitting multiple sclerosis in people experiencing their first symptoms of the condition, a study published in the New England Journal of Medicine has found.…